retatrutide investigational drug weight loss How Does Make You Lose Weight? The Science of the "Triple G" Agonist Retatrutide: A Promising Option for

Learn more about your options Safety & Clinical Notes (High-Level) FAQ Why does oral NAD+ feel weaker on GLP-1

Retatrutide is more expensive in absolute terms but can deliver competitive or superior value per unit of outcome

2 Department of Endocrinology, SANKO University Faculty of Medicine, Gaziantep, Turkey Correspondence: Nimet Ylmaz, Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey, Email [email protected] Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual GLP-1/GIP receptor agonists are highly effective agents for the treatment of type 2 diabetes and obesity

Although these findings have generated considerable interest, most of the available evidence comes from laboratory and animal studies rather than large human clinical trials